000819297 001__ 819297
000819297 005__ 20220930130105.0
000819297 0247_ $$2doi$$a10.1515/ract-2015-2566
000819297 0247_ $$2ISSN$$a0033-8230
000819297 0247_ $$2ISSN$$a2193-3405
000819297 0247_ $$2WOS$$aWOS:000384108400001
000819297 0247_ $$2Handle$$a2128/16359
000819297 037__ $$aFZJ-2016-04998
000819297 041__ $$aEnglish
000819297 082__ $$a540
000819297 1001_ $$0P:(DE-Juel1)131840$$aQaim, Syed M.$$b0$$eCorresponding author
000819297 245__ $$aUses of alpha particles, especially in nuclear reaction studies and medical radionuclide production
000819297 260__ $$aBerlin$$bDe Gruyter$$c2016
000819297 3367_ $$2DRIVER$$aarticle
000819297 3367_ $$2DataCite$$aOutput Types/Journal article
000819297 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1515161442_2793
000819297 3367_ $$2BibTeX$$aARTICLE
000819297 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000819297 3367_ $$00$$2EndNote$$aJournal Article
000819297 520__ $$aAlpha particles exhibit three important characteristics: scattering, ionisation and activation. This article briefly discusses those properties and outlines their major applications. Among others, α-particles are used in elemental analysis, investigation and improvement of materials properties, nuclear reaction studies and medical radionuclide production. The latter two topics, dealing with activation of target materials, are treated in some detail in this paper. Measurements of excitation functions of α-particle induced reactions shed some light on their reaction mechanisms, and studies of isomeric cross sections reveal the probability of population of high-spin nuclear levels. Regarding medical radionuclides, an overview is presented of the isotopes commonly produced using α-particle beams. Consideration is also given to some routes which could be potentially useful for production of a few other radionuclides. The significance of α-particle induced reactions to produce a few high-spin isomeric states, decaying by emission of low-energy conversion or Auger electrons, which are of interest in localized internal radiotherapy, is outlined. The α-particle beam, thus broadens the scope of nuclear chemistry research related to development of non-standard positron emitters and therapeutic radionuclides.
000819297 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000819297 588__ $$aDataset connected to CrossRef
000819297 7001_ $$0P:(DE-Juel1)131849$$aSpahn, Ingo$$b1
000819297 7001_ $$0P:(DE-Juel1)131846$$aScholten, Bernhard$$b2
000819297 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b3
000819297 773__ $$0PERI:(DE-600)2039575-9$$a10.1515/ract-2015-2566$$gVol. 104, no. 9$$n9$$p601–624$$tRadiochimica acta$$v104$$x2193-3405$$y2016
000819297 8564_ $$uhttps://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.pdf$$yOpenAccess
000819297 8564_ $$uhttps://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.gif?subformat=icon$$xicon$$yOpenAccess
000819297 8564_ $$uhttps://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
000819297 8564_ $$uhttps://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000819297 8564_ $$uhttps://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000819297 8564_ $$uhttps://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000819297 8767_ $$92016-09-02$$d2016-10-05$$eReprint$$jZahlung erfolgt$$z100 Sonderdrucke, erhalten am 05.10.16
000819297 909CO $$ooai:juser.fz-juelich.de:819297$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000819297 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000819297 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bRADIOCHIM ACTA : 2015
000819297 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000819297 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000819297 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000819297 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000819297 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000819297 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences
000819297 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000819297 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000819297 9141_ $$y2016
000819297 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131840$$aForschungszentrum Jülich$$b0$$kFZJ
000819297 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131849$$aForschungszentrum Jülich$$b1$$kFZJ
000819297 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131846$$aForschungszentrum Jülich$$b2$$kFZJ
000819297 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b3$$kFZJ
000819297 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000819297 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000819297 980__ $$ajournal
000819297 980__ $$aVDB
000819297 980__ $$aUNRESTRICTED
000819297 980__ $$aI:(DE-Juel1)INM-5-20090406
000819297 980__ $$aAPC
000819297 9801_ $$aAPC
000819297 9801_ $$aFullTexts